Deafness Clinical Trials


Hearing Aids and the Brain

Condition:   Hearing Loss
Intervention:   Device: hearing aids
Sponsor:   VA Office of Research and Development
Not yet recruiting - verified September 2017

Learn More

High Dose Oral Steroids in Sudden Sensorineural Hearing Loss

Condition:   Sudden Sensorineural Hearing Loss (SSNHL)
Interventions:   Drug: Dexamethasone;   Drug: Prednisone
Sponsor:   University of Colorado, Denver
Recruiting - verified September 2017

Learn More

Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation

Conditions:   Head and Neck Cancer;   Hearing Disorder;   Hyperlipidemia
Intervention:  
Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified July 18, 2017

Learn More

Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss

Condition:   Hearing Loss, Unilateral
Intervention:   Device: Cochlear implant
Sponsors:   University of North Carolina, Chapel Hill;   Med-El Corporation
Recruiting - verified September 2017

Learn More

Rilonacept for Treatment of Autoimmune Neurosensory Hearing Loss

Condition:   Autoimmune Neurosensory Hearing Loss (ANSHL)
Intervention:   Drug: Rilonacept
Sponsors:   Stanley Cohen;   Regeneron Pharmaceuticals
Recruiting - verified September 2017

Learn More

North Carolina Newborn Exome Sequencing for Universal Screening

Conditions:   Metabolism, Inborn Errors;   Hearing Loss;   Hereditary Disease
Interventions:   Genetic: Well infant, whole exome sequencing;   Genetic: Diagnosed, whole exome sequencing
Sponsors:   University of North Carolina, Chapel Hill;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Human Genome Research Institute (NHGRI);   RTI International
Recruiting - verified September 2017

Learn More

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment

Condition:   Hearing Loss, Idiopathic Sudden Sensorineural
Interventions:   Drug: AM-111 0.4 mg/ml;   Drug: AM-111 0.8 mg/ml;   Other: Placebo
Sponsor:   Auris Medical, Inc.
Recruiting - verified September 2017

Learn More

Inherited Retinal Degenerative Disease Registry

Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:  
Sponsor:   Foundation Fighting Blindness Clinical Research Institute
Recruiting - verified September 2017

Learn More

Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss

Condition:   Severe Unilateral Sensorineural Hearing Loss
Intervention:   Device: Cochlear implant
Sponsor:   Mayo Clinic
Recruiting - verified May 2017

Learn More

Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts

Conditions:   Sensorineural Hearing Loss;   Cytomegalovirus Infection
Intervention:  
Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified September 7, 2017

Learn More

Genetic Analysis of Hereditary Disorders of Hearing and Balance

Conditions:   Sensorineural Hearing Loss;   Hearing Disorder;   Vestibular Disease
Intervention:  
Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified August 22, 2017

Learn More

1-11 of 11
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.